These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17708394)

  • 21. Long-term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy.
    Vollmar AC; Fox PR
    J Vet Intern Med; 2016; 30(2):553-9. PubMed ID: 26936799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pimobendan on case fatality rate in Doberman Pinschers with congestive heart failure caused by dilated cardiomyopathy.
    O'Grady MR; Minors SL; O'Sullivan ML; Horne R
    J Vet Intern Med; 2008; 22(4):897-904. PubMed ID: 18537880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly - a randomised, double-blinded trial.
    Iwanuk N; Nolte I; Wall L; Sehn M; Raue J; Pilgram A; Rumstedt K; Bach JP
    BMC Vet Res; 2019 Jul; 15(1):237. PubMed ID: 31288807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a retrospective study of 141 cases.
    Kittleson M; Rishniw M; Pion P
    J Vet Intern Med; 2009; 23(3):445-6; author reply 447-8. PubMed ID: 19645830
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs.
    Lombard CW; Jöns O; Bussadori CM
    J Am Anim Hosp Assoc; 2006; 42(4):249-61. PubMed ID: 16822763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of plasma N-terminal pro-B-type natriuretic peptide concentration with mitral regurgitation severity and outcome in dogs with asymptomatic degenerative mitral valve disease.
    Chetboul V; Serres F; Tissier R; Lefebvre HP; Sampedrano CC; Gouni V; Poujol L; Hawa G; Pouchelon J-
    J Vet Intern Med; 2009; 23(5):984-94. PubMed ID: 19572913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study.
    Boswood A; Gordon SG; Häggström J; Wess G; Stepien RL; Oyama MA; Keene BW; Bonagura J; MacDonald KA; Patteson M; Smith S; Fox PR; Sanderson K; Woolley R; Szatmári V; Menaut P; Church WM; O'Sullivan ML; Jaudon JP; Kresken JG; Rush J; Barrett KA; Rosenthal SL; Saunders AB; Ljungvall I; Deinert M; Bomassi E; Estrada AH; Fernandez Del Palacio MJ; Moise NS; Abbott JA; Fujii Y; Spier A; Luethy MW; Santilli RA; Uechi M; Tidholm A; Schummer C; Watson P
    J Vet Intern Med; 2018 Jan; 32(1):72-85. PubMed ID: 29214723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST).
    Coffman M; Guillot E; Blondel T; Garelli-Paar C; Feng S; Heartsill S; Atkins CE
    J Vet Intern Med; 2021 Jul; 35(4):1673-1687. PubMed ID: 34028078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.
    de Madron E; King JN; Strehlau G; White RV
    Can Vet J; 2011 Nov; 52(11):1219-25. PubMed ID: 22547843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chordae tendineae rupture in dogs with degenerative mitral valve disease: prevalence, survival, and prognostic factors (114 cases, 2001-2006).
    Serres F; Chetboul V; Tissier R; Sampedrano CC; Gouni V; Nicolle AP; Pouchelon JL
    J Vet Intern Med; 2007; 21(2):258-64. PubMed ID: 17427386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased mitral valve regurgitation and myocardial hypertrophy in two dogs with long-term pimobendan therapy.
    Tissier R; Chetboul V; Moraillon R; Nicolle A; Carlos C; Enriquez B; Pouchelon JL
    Cardiovasc Toxicol; 2005; 5(1):43-51. PubMed ID: 15738584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doppler echocardiography-derived evidence of pulmonary arterial hypertension in dogs with degenerative mitral valve disease: 86 cases (2001-2005).
    Serres FJ; Chetboul V; Tissier R; Carlos Sampedrano C; Gouni V; Nicolle AP; Pouchelon JL
    J Am Vet Med Assoc; 2006 Dec; 229(11):1772-8. PubMed ID: 17144824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of pimobendan versus benazepril in canine myxomatous valvular disease.
    Boswood A; McEwan JD; French A; Little C; Swift S; Smith S; Patteson M
    Vet Rec; 2003 Oct; 153(14):439-40. PubMed ID: 14582738
    [No Abstract]   [Full Text] [Related]  

  • 34. Results of the multicenter spaniel trial (MUST): taurine- and carnitine-responsive dilated cardiomyopathy in American cocker spaniels with decreased plasma taurine concentration.
    Kittleson MD; Keene B; Pion PD; Loyer CG
    J Vet Intern Med; 1997; 11(4):204-11. PubMed ID: 9298474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Echocardiographic assessment of canine degenerative mitral valve disease.
    Chetboul V; Tissier R
    J Vet Cardiol; 2012 Mar; 14(1):127-48. PubMed ID: 22366573
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the angiotensin-converting enzyme inhibitor alacepril in dogs with mitral valve disease.
    Hori Y; Nakamura K; Kanno N; Hitomi M; Yamashita Y; Hosaka S; Isayama N; Mimura T
    J Vet Med Sci; 2018 Aug; 80(8):1212-1218. PubMed ID: 29937457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term effect of sildenafil on echocardiographic parameters in dogs with asymptomatic myxomatous mitral valve degeneration.
    Kijtawornrat A; Komolvanich S; Saengklub N; Pirintr P; Boonpala P; Buranakarl C
    J Vet Med Sci; 2017 Apr; 79(4):788-794. PubMed ID: 28302926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of treatment with pimobendan in dogs with preclinical mitral valve disease - a placebo-controlled double-blinded crossover study.
    Klein S; Nolte I; Rumstedt K; Sehn M; Raue JF; Weiner F; Treese JS; Beyerbach M; Bach JP
    BMC Vet Res; 2021 Sep; 17(1):310. PubMed ID: 34563187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurohormonal and circulatory effects of short-term treatment with enalapril and quinapril in dogs with asymptomatic mitral regurgitation.
    Moesgaard SG; Pedersen LG; Teerlink T; Häggström J; Pedersen HD
    J Vet Intern Med; 2005; 19(5):712-9. PubMed ID: 16231716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease.
    Bernay F; Bland JM; Häggström J; Baduel L; Combes B; Lopez A; Kaltsatos V
    J Vet Intern Med; 2010; 24(2):331-41. PubMed ID: 20102506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.